Navin Fluorine International Limited delivered another sharp earnings acceleration as CDMO, specialty chemicals and high-performance products all expanded in Q1 FY27. The results strengthen the case that years of capital expenditure are converting into revenue, but the share-price rally also raises the execution bar.